Blaine Kenaa1, Mary Elizabeth Richert2, Kimberly C Claeys3, Andrea Shipper4, Kaede V Sullivan5, Gregory M Schrank6, Lyndsay M O'Hara7, Daniel J Morgan7, Carl Shanholtz8, Surbhi Leekha7. 1. Department of Medicine, Department of Pulmonary and Critical Care, University of Maryland School of Medicine, 110 S. Paca st. Second floor pulmonary, Baltimore, MD, 21201, USA. Blaine.kenaa@som.umaryland.edu. 2. Division of Internal Medicine, PGY-3, Department of Medicine, University of Maryland School of Medicine, University of Maryland Medical Center, N3W42, 22 S. Greene Street, Baltimore, MD, 21201, USA. 3. Infectious Diseases, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, 20 N. Pine Street, Baltimore, MD, 21201, USA. 4. Health Sciences and Human Services Library, University of Maryland Baltimore, 601 W. Lombard St., Baltimore, MD, 21201, USA. 5. Pathology and Laboratory Medicine, Medicine Education and Research Building, Lewis Katz School of Medicine, 3500 N. Broad St., Philadelphia, PA, 19140, USA. 6. Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, University of Maryland Medical Center, N3W42, 22 S. Greene Street, Baltimore, MD, 21201, USA. 7. Department of Epidemiology and Public Health, University of Maryland School of Medicine, 685 W. Baltimore Street, Baltimore, MD, 21201, USA. 8. Department of Medicine, Department of Pulmonary and Critical Care, University of Maryland School of Medicine, 110 S. Paca st. Second floor pulmonary, Baltimore, MD, 21201, USA.
Abstract
PURPOSE OF REVIEW: Ventilator-associated pneumonia (VAP) is one of the most common infections in the ICU. Prompt diagnosis is vital as mortality increases with delayed antibiotic therapy. However, accurate diagnosis is challenging due to non-specific clinical features in a complicated patient cohort. Microbiological culture data remains a crucial aspect in confirming diagnosis. RECENT FINDINGS: Literature data comparing the benefit of invasive respiratory sampling to non-invasive is inconclusive. Differences in culturing practices translate in overidentification of organisms of unclear significance. Positive culture data in a low pre-test probability does not differentiate between true infection and colonization resulting in overtreatment. Furthermore, there are also opportunities for modifying the reporting of respiratory tract cultures that can better guide antimicrobial therapy. Under the umbrella of antimicrobial stewardship, diagnostic stewardship can be incorporated to create a systematic approach that would target culturing practices to match the right pre-test probability. Ideal outcome will be targeting cultures to the right patient population and minimizing unnecessary treatment.
PURPOSE OF REVIEW: Ventilator-associated pneumonia (VAP) is one of the most common infections in the ICU. Prompt diagnosis is vital as mortality increases with delayed antibiotic therapy. However, accurate diagnosis is challenging due to non-specific clinical features in a complicated patient cohort. Microbiological culture data remains a crucial aspect in confirming diagnosis. RECENT FINDINGS: Literature data comparing the benefit of invasive respiratory sampling to non-invasive is inconclusive. Differences in culturing practices translate in overidentification of organisms of unclear significance. Positive culture data in a low pre-test probability does not differentiate between true infection and colonization resulting in overtreatment. Furthermore, there are also opportunities for modifying the reporting of respiratory tract cultures that can better guide antimicrobial therapy. Under the umbrella of antimicrobial stewardship, diagnostic stewardship can be incorporated to create a systematic approach that would target culturing practices to match the right pre-test probability. Ideal outcome will be targeting cultures to the right patient population and minimizing unnecessary treatment.
Authors: Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek Journal: Clin Infect Dis Date: 2016-07-14 Impact factor: 9.079
Authors: Michael Klompas; Ken Kleinman; Yosef Khan; R Scott Evans; James F Lloyd; Kurt Stevenson; Matthew Samore; Richard Platt Journal: Clin Infect Dis Date: 2012-02-01 Impact factor: 9.079
Authors: Jean Baptiste Lascarrou; Floriane Lissonde; Aurélie Le Thuaut; Konstantinos Bachoumas; Gwenhael Colin; Matthieu Henry Lagarrigue; Isabelle Vinatier; Maud Fiancette; Jean Claude Lacherade; Aihem Yehia; Aurélie Joret; Christine Lebert; Sandra Bourdon; Laurent Martin Lefèvre; Jean Reignier Journal: Crit Care Med Date: 2017-08 Impact factor: 7.598
Authors: Kirthana Raman; Michael D Nailor; David P Nicolau; Jaber Aslanzadeh; Michelle Nadeau; Joseph L Kuti Journal: Crit Care Med Date: 2013-07 Impact factor: 7.598
Authors: Mohamed Sarg; Greer E Waldrop; Mona A Beier; Emily L Heil; Kerri A Thom; Michael Anne Preas; J Kristie Johnson; Anthony D Harris; Surbhi Leekha Journal: Infect Control Hosp Epidemiol Date: 2016-01-18 Impact factor: 3.254
Authors: R M Schnabel; K van der Velden; A Osinski; G Rohde; P M H J Roekaerts; D C J J Bergmans Journal: BMC Pulm Med Date: 2015-09-29 Impact factor: 3.317
Authors: Emma Browne; Thomas P Hellyer; Simon V Baudouin; Andrew Conway Morris; Vanessa Linnett; Danny F McAuley; Gavin D Perkins; A John Simpson Journal: BMJ Open Respir Res Date: 2014-12-16
Authors: Joseph Y Ting; Julie Autmizguine; Michael S Dunn; Julie Choudhury; Julie Blackburn; Shikha Gupta-Bhatnagar; Katrin Assen; Julie Emberley; Sarah Khan; Jessica Leung; Grace J Lin; Destiny Lu-Cleary; Frances Morin; Lindsay L Richter; Isabelle Viel-Thériault; Ashley Roberts; Kyong-Soon Lee; Erik D Skarsgard; Joan Robinson; Prakesh S Shah Journal: Front Pediatr Date: 2022-07-08 Impact factor: 3.569